Competitive 5-Aminothiazole-4-Carboxamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172
or mail to
sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
5-Aminothiazole-4-carboxamide (CAS 454-91-1), molar mass 143.17 g mol⁻¹, molecular formula C₄H₅N₃OS, is supplied as a light‑yellow to beige crystalline powder. The compound carries a primary amine at the thiazole 5‑position and a carboxamide at C4, giving it a distinct regiochemistry that separates it from the more extensively utilised 2‑aminothiazole‑4‑carboxamide isomer. Standard commercial specifications align with a purity (HPLC, C18, 254 nm) of ≥98.0 area‑%, a melting endotherm (DSC, 10 K min⁻¹, nitrogen purge) with onset at 208–212 °C (decomposition), Karl Fischer water content ≤0.5 wt%, and sulfated ash ≤0.10 wt% (USP 〈281〉). Heavy metals as lead are controlled to ≤20 ppm (USP 〈231〉 Method II). The residual solvent profile is monitored against ICH Q3C Option 1 limits; typical lot data show DMF below 880 ppm and dichloromethane below 600 ppm. Identity is confirmed by FT‑IR (characteristic C=O stretch at ~1650 cm⁻¹ and NH₂ scissoring at ~1580 cm⁻¹) and 1H NMR (DMSO‑d₆, 400 MHz) with signals at δ 7.92 (s, 1H, thiazole‑H2), δ 7.25 (br s, 2H, NH₂), and δ 6.80 (br s, 2H, CONH₂).
Comparative lot‑release data for two supply grades of 5‑aminothiazole‑4‑carboxamide
| Parameter | Research grade | GMP intermediate grade | Test method |
| Assay (anhydrous, non‑volatile free base) | 98.0–101.0 % | 99.0–101.5 % | HPLC with external standard; column: C18, 150×4.6 mm, 5 µm; mobile phase water/acetonitrile + 0.1% TFA |
| Water | ≤0.5 % | ≤0.2 % | KF coulometric (USP〈921〉) |
| Residue on ignition | ≤0.10 % | ≤0.05 % | USP〈281〉 |
| Endotoxins | Not tested | ≤0.05 EU mg⁻¹ | USP〈85〉; LAL kinetic‑chromogenic |
| Residual solvents | Reported | Within ICH Q3C Option 1 limits; Class 2 solvents individual ≤ 880 ppm, total ≤ 3000 ppm | HS‑GC‑FID |
| Heavy metals | ≤20 ppm | ≤10 ppm | USP〈231〉 Method II |
The compound is hygroscopic; exposure to ambient air (25 °C, 60 % RH) increases water content by 0.3–0.6 wt% within 2 h. Containers are therefore purged with dry nitrogen and sealed with a desiccant sachet. Unopened material stored at 2–8 °C in the original aluminium‑laminated bag retains the certified purity for 24 months from the date of manufacture.
Regioisomeric substitution and its impact on coupling chemistries
The 5‑amino group exhibits attenuated basicity compared with the 2‑amino isomer; potentiometric titration in water/methanol (50:50 v/v) yields a pKₐ of approximately 3.5 ± 0.3, whereas the 2‑amino isomer is protonated at pKₐ ~4.1. This shift reduces the fraction of unreactive ammonium salt during amide‑bond formation in weakly basic media. Activation of the 4‑carboxamide toward nucleophilic substitution is minimal, but the amide nitrogen can be further derivatised through Hofmann rearrangement after protection. Direct Suzuki–Miyaura coupling at the thiazole ring requires prior installation of a halogen; 5‑aminothiazole‑4‑carboxamide is brominated regioselectively at C2 using N‑bromosuccinimide in DMF at 0–5 °C, giving the 2‑bromo intermediate in 72–85 % isolated yield on 100‑g scale, while the 2‑amino isomer undergoes electrophilic substitution preferentially at C5, generating a different scaffold.
Upon activation of the carboxylic acid partner with HATU and N‑methylmorpholine in DMF, the 5‑amino group couples smoothly with aliphatic and aromatic acids at 0–10 °C; conversion exceeds 98 % after 6 h when the free‑amine concentration is kept below 0.3 M. Under identical conditions the 2‑amino analogue requires higher excess of the acid component to compensate for competing protonation.
What distinguishes 5-aminothiazole-4-carboxamide from its 2-amino counterparts in drug design?
In kinase inhibitor programmes targeting the hinge‑binding region, the hydrogen‑bond donor/acceptor geometry of the 5‑amino‑4‑carbamoyl motif deviates by roughly 60° from that of the 2‑amino isomer. This rotation alters the vector of the amide substituent when coupled to a hinge‑binder core, which has been exploited in multiple disclosed ATP‑competitive inhibitors. The 5‑amino group forms a bidentate interaction with the backbone carbonyl and NH of the gatekeeper residue when the thiazole is incorporated into a fused biaryl system, whereas the 2‑amino isomer tends to engage a single hydrogen‑bonding pocket. Docking studies with a panel of tyrosine kinases (ABL1, SRC, EGFR) indicate that the free‑energy perturbation imposed by the regioisomer swap averages 1.2–1.8 kcal mol⁻¹ (MM‑GBSA) depending on the water network in the active site, a range sufficient to shift selectivity profiles. Published lead‑optimisation campaigns have leveraged this difference to reduce off‑target activity against hERG and CYP isoforms while maintaining target potency, though the magnitude of the effect is sequence‑dependent.
A further practical distinction emerges during scale‑up: the 5‑amino‑4‑carboxamide is less susceptible to oxidative dimerisation in solution because the amino group is not directly conjugated with the ring sulfur to the same extent as in the 2‑amino series. Accelerated stability testing (40 °C/75 % RH, open vial, 7 days) showed dimer formation by UPLC‑MS at 0.7 area‑% for the 5‑amino isomer versus 2.4 area‑% for the 2‑amino isomer, a factor attributed to a higher N‑centred radical stabilisation energy in the latter.
Scale-Up Reactor Configuration for Amide Bond Formation Using 5-Aminothiazole-4-Carboxamide
Reaction calorimetry (Mettler‑Toledo RC1e) of the coupling with 4‑(trifluoromethyl)benzoic acid in DMF using HATU/DIPEA revealed a total heat release of 104 kJ mol⁻¹ of amide product, with a maximum heat flow of 380 W L⁻¹ at the point of acid chloride addition. Scaling the process to a 1600 L glass‑lined vessel (jacket U‑coefficient 120 W m⁻² K⁻¹) imposes a dosing‑controlled semi‑batch mode where the acid‑HATU pre‑activation mixture is metered over 90 min while the jacket circulates a glycol‑water mix at −15 °C. The internal temperature is maintained at 2–5 °C. Process analytical technology (ReactIR 45 m, K6 conduit) monitors the disappearance of the isourea‑ester intermediate (peak 1725 cm⁻¹); a hold step is triggered when the signal falls below 5 % of the initial absorbance. Deviation of the internal temperature above 8 °C during the dosing phase results in a bis‑acylated by‑product (confirmed by HRMS) that reaches 2.8 area‑% and cannot be adequately purged by slurry washing with MTBE alone, requiring a hot‑filtration through a 0.2 µm cartridge at 50 °C to drop below the 0.15 area‑% specification for the crude intermediate. After 12 h age‑time the batch is quenched with 5 vol of water, the slurry filtered on a Nutsche filter‑dryer, washed with water and heptane, and dried under vacuum (50 °C, 10 mbar) to constant loss on drying (≤0.3 %, ASTM E1868). The isolated yield spans 80–88 %, with the bottleneck being the water‑wet cake handling time, which if extended beyond 8 h at ambient temperature promotes amide hydrolysis to the acid (0.6 % h⁻¹ rate constant observed at 22 °C).
During the route scouting for a CRTh2 antagonist candidate, the research group encountered a processing window of ±3 °C for the Boc protection of 5‑aminothiazole‑4‑carboxamide using di‑tert‑butyl dicarbonate in THF/water. At temperatures below 0 °C the reaction stalled at 70 % conversion after 20 h, while above 8 °C rapid decomposition of the Boc‑anhydride generated isobutylene and CO₂, pressurising the reactor to 0.5 bar gauge and causing foaming that overran the 2000 L vessel’s vapour‑disengagement volume. The resolved protocol used a jacketed temperature control with tolerance ±1 °C, and the feed of Boc₂O was split into six equal portions dosed at 15‑min intervals, each followed by a pH adjustment to 8.5–9.0 with 2 N NaOH to scavenge the liberated t‑butanol‑derived acidity.
Moisture Uptake and Packaging Requirements for Long-Term Stability
Dynamic vapour sorption analysis (DVS Intrinsic, SMS Ltd) over a 0–90 % RH cycle at 25 °C shows a 1.8 wt% mass increase at 60 % RH and 4.2 wt% at 80 % RH. The sorption isotherm exhibits hysteresis, indicating formation of a meta‑stable monohydrate that reverts slowly upon desiccation. Material processed in an ISO 14644‑1 Class 8 cleanroom must therefore be dried immediately under nitrogen flow before packaging. The specified packaging configuration, qualified following ASTM D4169‑16 distribution cycle testing, employs a double‑polyethylene liner inside a fibreboard drum, with a molecular sieve desiccant (4A, 100 g per 10 kg of product) and an oxygen absorber sachet. Container closure integrity is verified by helium leak detection (detection limit 6×10⁻⁸ Pa m³ s⁻¹).
Quality control retains samples undergo an annual check for appearance, HPLC purity, and water content; data from 18 batches stored over 36 months at 2–8 °C show no significant linear degradation trend (ANOVA p‑value 0.42 for purity endpoint), confirming the assigned retest period.
When 5-Aminothiazole-4-Carboxamide is Used as a Key Intermediate in Continuous Flow Processes
The moderate solubility of the free amine in non‑protic solvents (approx. 12 g L⁻¹ in DMF, 8 g L⁻¹ in acetonitrile at 25 °C) becomes a limitation in a continuous plug‑flow reactor. To achieve a 0.25 M feed concentration for a subsequent SNAr step, a slurry‑to‑solution system was implemented where the solid is pre‑dissolved in a 50 °C DMF stream using a jacketed, magnetically driven agitated vessel, filtered in‑line through a 60 µm sintered‑metal frit, and fed into a Corning Advanced‑Flow G1 reactor. Below 40 °C the solution is metastable; precipitation of the amine‑HCl salt occurs within the residence‑time module when the chloride counter‑ion is introduced, causing a rapid increase in pressure drop from 0.8 bar to 2.4 bar within 20 min of operation. Mitigation is achieved by incorporating a 10 mol% excess of a hindered organic base (2,6‑lutidine) relative to the amine and installing an ultrasonic probe on the first reactor plate, which reduces particle size to ≤15 µm and prevents channel blockage for runs exceeding 8 h. The productivity achieved, 1.8 kg h⁻¹ of isolated Intermediate‑X, represents a four‑fold improvement over a batch process with identical volumetric productivity per reactor footprint.
During a routine analysis of an R&D batch, an unknown impurity eluting at relative retention time 1.32 (HPLC Method AT‑4‑A) reached 0.21 area‑% after stress at 60 °C in 1 N HCl for 4 h. HRMS and 13C NMR identified the species as the ring‑opened thiazoline derivative; its formation indicated that strong acid conditions should be avoided in work‑up and that the pH of aqueous quenches during amide coupling must be maintained above 3.0. This observation was subsequently incorporated into the Process Development Report and triggered the addition of an IPC limit of NMT 0.10 area‑% for this degradant before the crystallisation step.
Key property comparison of three aminothiazole carboxamide regioisomers
| Property | 5‑Aminothiazole‑4‑carboxamide | 2‑Aminothiazole‑4‑carboxamide | 2‑Aminothiazole‑5‑carboxamide |
| CAS RN | 454‑91‑1 | 2153‑18‑0 | 2153‑19‑1 |
| Melting range (DSC onset, decomp.) | 208–212 °C | 198–203 °C | 210–215 °C |
| Solubility in DMSO (25 °C, g L⁻¹) | ~40 | ~55 | ~35 |
| Observed pKₐ (NH₂) | ~3.5 | ~4.1 | ~3.8 |
| Predominant electrophilic substitution site | C2 | C5 | C4 (when free); mostly inert |
| Rate of oxidative dimerisation (AOM, 40 °C/75 % RH, 7 d) | 0.7 area‑% | 2.4 area‑% | 1.9 area‑% |
| Typical residual solvent after tray drying | DMF < 500 ppm | Ethanol < 200 ppm | Methanol < 300 ppm |